News from alexza pharmaceuticals, inc

Jun 30, 2014, 16:15 ET

Alexza Announces the Promotion of Edwin S. Kamemoto, Ph.D. to Senior Vice President, Regulatory Affairs

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced the promotion of Edwin S. Kamemoto, Ph.D., to the newly created position of Senior Vice...

May 05, 2014, 16:05 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Reports 2014 First Quarter Financial Results

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter ended March 31, 2014.  The net loss for the first...

Apr 30, 2014, 16:05 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Pharmaceuticals Announces the Launch of ADASUVE® (inhalation powder, loxapine) in the Nordic Countries

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that ADASUVE® inhalation powder, pre-dispensed (loxapine) is now available in...

Apr 17, 2014, 09:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Winston R. Brown, Jr. Joins Alexza Pharmaceuticals as Vice President, Quality

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that Winston R. Brown, Jr. has joined the Company as Vice President,...

Apr 16, 2014, 16:30 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza to Report 2014 First Quarter Financial Results on Monday, May 5, 2014

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal quarter ended March 31, 2014 on Monday, May 5, 2014, following the...

Mar 19, 2014, 09:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Pharmaceuticals Announces Private Placement of $45 Million of Non-Recourse Notes

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) (Alexza) announced today that it has closed a private placement to institutional investors of $45.0...

Mar 13, 2014, 09:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Pharmaceuticals and Ferrer Announce the Launch of ADASUVE® (inhalation powder, loxapine) in Romania

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Ferrer today announced that ADASUVE® inhalation powder, pre-dispensed (loxapine) is now...

Mar 06, 2014, 16:05 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Reports Fourth Quarter and Year End 2013 Financial Results

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter and year ended December 31, 2013.  The net...

Mar 03, 2014, 08:07 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Announces the U.S. Commercial Launch of ADASUVE® by Teva Pharmaceuticals

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced the U.S. commercial launch of ADASUVE® (loxapine) inhalation powder 10mg by its...

Feb 25, 2014, 09:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Robert A. Lippe Joins Alexza Pharmaceuticals as Executive Vice President, Operations and Chief Operations Officer

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that Robert A. Lippe has joined the Company as Executive Vice President, Operations...

Feb 20, 2014, 17:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Pharmaceuticals' Corporate Presentation to be Webcast from Two Upcoming March Investor Conferences

Alexza Pharmaceuticals' Corporate Presentation to be Webcast from Two Upcoming March Investor Conferences /* Style Definitions...

Feb 13, 2014, 09:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza to Report 2013 Year-End Financial Results on Thursday, March 6, 2014

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal year ended December 31, 2013 on Thursday, March 6, 2014, following...

Jan 21, 2014, 09:05 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Pharmaceuticals Announces Ferrer's Launch of ADASUVE® (Staccato® Loxapine) in Spain Triggering a $1 Million Milestone Payment

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that ADASUVE® inhalation powder, pre-dispensed (Staccato® loxapine) is...

Nov 21, 2013, 16:15 ET

Alexza Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the Company will participate in the 25th Annual Piper Jaffray Healthcare...

Nov 06, 2013, 16:05 ET

Alexza Reports 2013 Third Quarter Financial Results

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter ended September 30, 2013.  The net loss for...

Oct 24, 2013, 09:00 ET

Alexza Pharmaceuticals and Grupo Ferrer Announce the Launch of ADASUVE® (Staccato® Loxapine) in Austria

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Grupo Ferrer Internacional, S.A. (Ferrer) today announced that ADASUVE® inhalation powder,...

Oct 16, 2013, 16:15 ET

Alexza to Report 2013 Third Quarter Financial Results on Wednesday, November 6, 2013

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal quarter ended September 30, 2013 on Wednesday, November 6,...

Aug 29, 2013, 16:15 ET

Alexza Pharmaceuticals to Present at the Stifel Healthcare Conference 2013

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the Company will participate in the Stifel Healthcare Conference 2013, being...

Aug 08, 2013, 16:05 ET

Alexza Reports Preliminary 2013 Second Quarter Financial Results

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported preliminary financial results for the quarter ended June 30, 2013.  The preliminary...

Aug 06, 2013, 16:15 ET

Alexza Pharmaceuticals to Present at the 2013 Wedbush Life Sciences Management Access Conference

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the Company will participate in the 2013 Wedbush Life Sciences Management...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer